Cargando…

The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration: A Prospective Bicentric Study

Patients with cirrhosis are vulnerable to acute hepatic insults and are more likely to develop rapid hepatic deterioration. The aim of this study is to describe the clinical course of patients with cirrhosis and hospitalized for acute hepatic deterioration (AHD). This is a prospective study involvin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yu, Yan, Huadong, Zhou, Zhibo, Fang, Hong, Li, Jiawei, Ye, Honghua, Sun, Wenjie, Zhou, Wenhong, Ye, Jingfen, Yang, Qiao, Yang, Ying, Hu, Yaoren, Chen, Zhi, Sheng, Jifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058970/ https://www.ncbi.nlm.nih.gov/pubmed/26632701 http://dx.doi.org/10.1097/MD.0000000000002031

Ejemplares similares

AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis
por: Mao, Weilin, et al.
Publicado: (2016)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report
por: Jung, Tae Yang, et al.
Publicado: (2017)

Clinical characteristics of cirrhosis patients with umbilical vein recanalization: A retrospective analysis
por: Shi, Qing, et al.
Publicado: (2021)

Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
por: Yan, Li-Ting, et al.
Publicado: (2020)

Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Fatal hepatic failure following atorvastatin treatment: A case report
por: Wang, Huajun, et al.
Publicado: (2023)

Course of hepatitis E infection in a patient with rheumatoid arthritis and autoimmune hepatitis: A case report
por: Thodou, Victoria, et al.
Publicado: (2017)

CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
por: Jeong, Jin Hee, et al.
Publicado: (2016)

The role of IL22 polymorphisms on liver cirrhosis in patients with hepatitis B virus: A case control study
por: Gao, Yan-Hang, et al.
Publicado: (2019)

Factors associated with nonadherence to surveillance for hepatocellular carcinoma among patients with hepatic C virus cirrhosis, 2000–2015
por: Chang, Shen-Shong, et al.
Publicado: (2022)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis
por: Zhang, Tianyao, et al.
Publicado: (2019)

Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report
por: Yan, Xin, et al.
Publicado: (2018)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis in a hepatitis C virus infected population
por: Saleem, Nabil, et al.
Publicado: (2021)

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
por: Liu, Yanqiong, et al.
Publicado: (2015)

Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
por: Zhou, Jing, et al.
Publicado: (2019)

Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis
por: Huang, Long, et al.
Publicado: (2022)

Spleen stiffness-spleen size-to-platelet ratio risk score as noninvasive predictors of esophageal varices in patients with hepatitis B virus-related cirrhosis
por: Cho, Young Seo, et al.
Publicado: (2022)

Clinical study of transjugular intrahepatic portosystemic shunt combined with AngioJet thrombectomy for acute portal vein thrombosis in non-cirrhosis
por: Li, Zhaonan, et al.
Publicado: (2021)

Liver cirrhosis caused by chronic Budd–Chiari syndrome
por: Lin, Mengjie, et al.
Publicado: (2017)

The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis
por: Sato, Shinya, et al.
Publicado: (2021)

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients
por: Li, Min-Ran, et al.
Publicado: (2016)

Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension
por: Maruyama, Hitoshi, et al.
Publicado: (2015)

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
por: Sahin, Tolga, et al.
Publicado: (2020)

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article
por: Shin, Seung Kak, et al.
Publicado: (2017)

Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients
por: Zhou, Pu, et al.
Publicado: (2015)

Primarily isolated hepatic involvement of amyloidosis: A case report and overview
por: Ye, Lei, et al.
Publicado: (2016)

Postoperative course of Crohn disease according to timing of bowel resection: Results from the CONNECT Study
por: Lee, Ji Min, et al.
Publicado: (2018)

Increased Risks of Spontaneous Bacterial Peritonitis and Interstitial Lung Disease in Primary Biliary Cirrhosis Patients With Concomitant Sjögren Syndrome
por: Chen, Chun-Ting, et al.
Publicado: (2016)

The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China
por: Li, Qiang, et al.
Publicado: (2016)

Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis
por: Kim, Jung Ho, et al.
Publicado: (2016)

Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t72up6dcg055h7h3bsg4ck4gl0